3-(4-Methoxyphenyl)-5-[[[4-(4-methoxyphenyl)-5-methyl-4H-1,2,4-triazol-3-yl]thio]methyl]-1,2,4-oxadiazole;TC-E 5001;TC E 5001,TCE 5001;1,2,4-Oxadiazole, 3-(4-methoxyphenyl)-5-[[[4-(4-methoxyphenyl)-5-methyl-4H-1,2,4-triazol-3-yl]thio]methyl]-;Tankyrase1/2 Inhibitor III
TC-E 5001 is a Wnt pathway inhibitor that suppresses tankyrase 1/2 (TNKS1/2) by binding to a novel adenosine pocket, with Kd values of 79 nM and 28 nM, respectively; it also inhibits Axin2 and STF with IC50 values of 0.709 μM and 0.215 μM.